Cargando…

Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens

Adenoviruses are highly immunogenic and are being examined as potential vectors for immunotherapy. Infection by oncolytic adenovirus is followed by massive autophagy in cancer cells. Here, we hypothesize that autophagy regulates the processing of adenoviral proteins for antigen presentation. To test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Sarah R., Jiang, Hong, Hossain, Mohammad B., Fan, Xuejun, Gumin, Joy, Dong, Andrew, Alonso, Marta M., Gomez-Manzano, Candelaria, Fueyo, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836716/ https://www.ncbi.nlm.nih.gov/pubmed/27093696 http://dx.doi.org/10.1371/journal.pone.0153814

Ejemplares similares

Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity
por: Jiang, Hong, et al.
Publicado: (2023)

GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
por: Rivera-Molina, Yisel, et al.
Publicado: (2019)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
por: Matthews, Qiana L, et al.
Publicado: (2008)

Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
por: Cortes-Santiago, Nahir, et al.
Publicado: (2016)

Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
por: Jiang, Hong, et al.
Publicado: (2014)

The E1B19K Oncoprotein Complexes with Beclin 1 to Regulate Autophagy in Adenovirus-Infected Cells
por: Piya, Sujan, et al.
Publicado: (2011)

C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy
por: Klein, SR, et al.
Publicado: (2015)

IMMU-06. DELTA-24-RGD EXPRESSING POSITIVE IMMUNE MODULATORS SHOW ANTI-DIPG EFFECT AND INCREASE TUMOR IMMUNE INFILTRATION
por: Laspidea, Virginia, et al.
Publicado: (2021)

Potentiation of anti-glioma immunity induced by oncolytic adenovirus Delta-24-RGD through viral expression of immune co-stimulator OX40 ligand
por: Jiang, Hong, et al.
Publicado: (2015)

Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma
por: Xipell, Enric, et al.
Publicado: (2016)

Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model()()
por: Gabrusiewicz, Konrad, et al.
Publicado: (2015)

HGG-15. THE IMIPRIDONE ONC201 IN COMBINATION WITH THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD HAS A SYNERGISTIC EFFECT IN PRECLINICAL MODELS OF PHGGS AND DMGS
por: de la Nava, Daniel, et al.
Publicado: (2021)

Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
por: Shin, Dong Ho, et al.
Publicado: (2021)

Evaluation of adenovirus capsid labeling versus transgene expression
por: Li, Jing, et al.
Publicado: (2010)

Multivalent adenoviral vectors which use an antigen capsid-incorporation strategy for HIV vaccination
por: Gu, L, et al.
Publicado: (2012)

Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
por: Martinez-Velez, Naiara, et al.
Publicado: (2022)

IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas
por: Labiano, Sara, et al.
Publicado: (2022)

Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
por: Nguyen, Teresa T, et al.
Publicado: (2022)

Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
por: Salisch, Nadine C., et al.
Publicado: (2017)

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
por: Varela-Guruceaga, Maider, et al.
Publicado: (2018)

Viral Capsid Is a Pathogen-Associated Molecular Pattern in Adenovirus Keratitis
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2010)

A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry
por: Wodrich, Harald, et al.
Publicado: (2010)

Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
por: Smith, Jason G., et al.
Publicado: (2010)

Remission of liquid tumors and SARS-CoV-2 infection: A literature review
por: Shin, Dong Ho, et al.
Publicado: (2022)

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy
por: Gu, Linlin, et al.
Publicado: (2014)

Development of an Ad5H3 Chimera Using the “Antigen Capsid-Incorporation” Strategy for an Alternative Vaccination Approach
por: Gu, Linlin, et al.
Publicado: (2016)

Adenovirus core protein V reinforces the capsid and enhances genome release from disrupted particles
por: Martín-González, Natalia, et al.
Publicado: (2023)

IMMU-01. THE ONCOLYTIC VIRUS DELTA-24-RGD IN COMBINATION WITH AN AGONISTIC CD40 MAB INDUCES A DURABLE AND SYNERGISTIC ANTI-TUMOR IMMUNE EFFECT IN DIPG PRECLINICAL MODELS
por: Labiano, Sara, et al.
Publicado: (2021)

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions
por: Weklak, Denice, et al.
Publicado: (2021)

Tie2/TEK Modulates the Interaction of Glioma and Brain Tumor Stem Cells with Endothelial Cells and Promotes an Invasive Phenotype
por: Liu, Dan, et al.
Publicado: (2010)

DIPG-10. DELTA-24-RGDOX PROMOTES ANTITUMOR IMMUNE RESPONSE IN DMG MODELS
por: Laspidea, Virginia, et al.
Publicado: (2023)

HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach
por: Matthews, Qiana L., et al.
Publicado: (2010)

THER-09. ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
por: Iñigo-Marco, Ignacio, et al.
Publicado: (2020)

Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
por: Im, S-A, et al.
Publicado: (2001)

An Intrinsically Disordered Region of the Adenovirus Capsid Is Implicated in Neutralization by Human Alpha Defensin 5
por: Flatt, Justin W., et al.
Publicado: (2013)

Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile
por: White, Katie M, et al.
Publicado: (2013)

A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy
por: Wang, Lizheng, et al.
Publicado: (2020)

Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution
por: Reddy, Vijay S., et al.
Publicado: (2022)

Multi-layered control of Galectin-8 mediated autophagy during adenovirus cell entry through a conserved PPxY motif in the viral capsid
por: Montespan, Charlotte, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c3c5askcorbh01qf1hnuvajvc0